Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05377827
Title	Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Washington University School of Medicine
Indications	anaplastic large cell lymphoma angioimmunoblastic T-cell lymphoma T-cell prolymphocytic leukemia acute myeloid leukemia Sezary's disease peripheral T-cell lymphoma nasal type extranodal NK/T-cell lymphoma non-Hodgkin lymphoma adult T-cell leukemia/lymphoma primary cutaneous gamma-delta T-cell lymphoma hepatosplenic T-cell lymphoma
Therapies	WU-CART-007
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Washington University School of Medicine	RECRUITING	Saint Louis	Missouri	63110	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field